Iovance Biotherapeutics to Present at Upcoming Conferences Apr 30, 2024 06:01AM
Iovance Biotherapeutics to Present at Upcoming Conferences Apr 24, 2023 07:01AM
Iovance Biotherapeutics to Present at Upcoming Conferences Apr 24, 2023 07:01AM
Iovance Biotherapeutics to Present at Chardan Genetic Medicines and Cell Therapy Manufacturing Summit Apr 25, 2022 04:01PM
Iovance Biotherapeutics to Present at Chardan Genetic Medicines and Cell Therapy Manufacturing Summit Apr 25, 2022 04:01PM


Feb 25, 2022 07:12AM Iovanace Biotherapeutics (IOVA) PT Lowered to $45 at Chardan Capital Markets
May 19, 2021 07:58AM Iovanace Biotherapeutics (IOVA) PT Lowered to $51 at Chardan Capital Markets on BLA Delay
Oct 6, 2020 08:38AM Iovanace Biotherapeutics (IOVA) PT Lowered to $50 at Chardan Capital Markets on Delay
Nov 8, 2019 08:53AM Iovanace Biotherapeutics (IOVA) PT Raised to $33 at Chardan Capital Markets
May 20, 2019 08:36AM Iovanace Biotherapeutics (IOVA) PT Raised to $30 at Chardan Capital Markets
Jul 6, 2018 08:09AM Iovanace Biotherapeutics (IOVA) PT Maintained at $30 at Chardan Capital Markets; 'Market Misunderstandings' Offer 'Buying Opportunity Ahead of Data'
Jan 22, 2018 09:22AM Iovanace Biotherapeutics (IOVA) PT Raised to $30 at Chardan Capital Markets, Top Pick for 2018
Sep 25, 2017 04:01PM Iovance Biotherapeutics, Inc. Announces Closing of $57.5 Million Common Stock Public Offering
Sep 21, 2017 05:53AM Iovance Biotherapeutics (IOVA) Prices 7.692M Share Common Offering at $6.50/Sh
Sep 20, 2017 06:07PM Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of $50 Million of Common Stock
Sep 1, 2017 06:16AM Iovanace Biotherapeutics (IOVA): Fast Track Status Validates Regulatory Path - Chardan